Schrödinger
Update in progressSDGR (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryHealth Information Services
Schrödinger, Inc. and its subsidiaries develop a physics-based computational platform that enables discovery of novel molecules for drug development and materials research worldwide. The company has two segments: Software, which markets tools to advance molecular discovery in life sciences and materials science; and Drug Discovery, which builds a portfolio of preclinical and clinical programs through internal efforts and collaborations. It has a research collaboration and license with Novartis to advance multiple development candidates. Incorporated in 1990 and based in New York, NY.
Company score
- Sentiment
- 0.12
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.09
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.13
- Governance
- -0.07
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.02
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.05
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!